Proangiogenic hydrogels within macroporous scaffolds enhance islet engraftment in an extrahepatic site

Tissue Engineering - Part A

Volumn 19, Issue 23-24, 2013, Pages 2544-2552

  Brady, Ann Christina ^a,b   Martino, Mikaël M ^c   Pedraza, Eileen ^a,d   Sukert, Steve ^a   Pileggi, Antonello ^a,b,d   Ricordi, Camillo ^a,b,d   Hubbell, Jeffrey A ^a,c   Stabler, Cherie L ^a,b,d  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c EPFL   (Switzerland)

^d University of Miami College of Engineering   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; MICROCHANNELS; SCAFFOLDS (BIOLOGY); STRESSES;

CLOSE PROXIMITY; INSULIN-PRODUCING CELLS; INTEGRIN-BINDING SITE; ISLET TRANSPLANTATION; PLATELET-DERIVED GROWTH FACTORS; POLYDIMETHYLSILOXANE PDMS; SYNERGISTIC EFFECT; TYPE 1 DIABETES;

HYDROGELS;

DIMETICONE; FIBRIN; FIBRONECTIN; GLUCOSE; GROWTH FACTOR; INTEGRIN; PLATELET DERIVED GROWTH FACTOR BB; TISSUE SCAFFOLD; VASCULOTROPIN A;

ALLOTRANSPLANTATION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CONTROLLED STUDY; ENGRAFTMENT; GLUCOSE BLOOD LEVEL; HYDROGEL; MALE; MOUSE; NONHUMAN; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; POROSITY; PRIORITY JOURNAL; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS;

ALLOGRAFTS; ANGIOGENESIS INDUCING AGENTS; ANIMALS; DIMETHYLPOLYSILOXANES; HYDROGELS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; NYLONS; POROSITY; PROTO-ONCOGENE PROTEINS C-SIS;

EID: 84889774436     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0686     Document Type: Article

References (46)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329, 977, 1993.
2. Pileggi, A., Cobianchi, L., Inverardi, L., and Ricordi, C. Overcoming the challenges now limiting islet transplantation: a sequential, integrated approach. Ann N Y Acad Sci 1079, 383, 2006.
3. Shapiro, A.M., Ricordi, C., Hering, B.J., Auchincloss, H., Lindblad R, Robertson, R.P., et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 355, 1318, 2006.
4. Hardy, M.A., Witkowski, P., Sondermeijer, H., and Harris, P. The long road to pancreatic islet transplantation. World J Surg 34, 625, 2010.
5. Cattan, P., Berney, T., Schena, S., Molano, R.D., Pileggi, A., Vizzardelli, C., et al. Early assessment of apoptosis in isolated islets of Langerhans. Transplantation 71, 857, 2001.
6. Mattsson, G., Jansson, L., Nordin, A., Andersson, A., and Carlsson, P.O. Evidence of functional impairment of syngeneically transplanted mouse pancreatic islets retrieved from the liver. Diabetes 53, 948, 2004.
7. Moberg, L., Johansson, H., Lukinius, A., Berne, C., Foss, A., Kallen, R., et al. Productions of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 360, 2039, 2002.
8. Merani, S., Toso, C., Emamaullee, J., and Shapiro, A.M. Optimal implantation site for pancreatic islet transplantation. Br J Surg 95, 1449, 2008.
9. Cantarelli, E., and Piemonti, L. Alternative transplantation sites for pancreatic islet grafts. Curr Diab Rep 11, 364, 2011.
10. Giraldo, J.A., Weaver, J.D., and Stabler, C.L. Tissue engineering approaches to enhancing clinical islet transplantation. J Diabetes Sci Technol 4, 1238, 2010.
11. Gibly, R.F., Graham, J.G., Luo, X., Lowe, W.L., Jr., Hering, B.J., and Shea, L.D. Advancing islet transplantation: from engraftment to the immune response. Diabetologia 54, 2494, 2011.
12. Borg, D., and Bonifacio, E. The Use of Biomaterials in Islet Transplantation. Curr Diabetes Rep 11, 434, 2011.
13. Gibly, R.F., Zhang, X., Graham, M.L., Hering, B.J., Kaufman, D.B., Lowe, W.L., Jr., et al. Extrahepatic islet transplantation with microporous polymer scaffolds in syngeneic mouse and allogeneic porcine models. Biomaterials 32, 9677, 2011.
14. Blomeier, H., Zhang, X., Rives, C., Brissova, M., Hughes, E., Baker, M., et al. Polymer scaffolds as synthetic microenvironments for extrahepatic islet transplantation. Transplantation 82, 452, 2006.
15. Pedraza, E., Brady, A., Fraker, C., Molano, R., Sukert, S., Kenyon, N., et al. Macro-porous PDMS scaffolds for extrahepatic islet transplantation. Cell Transplant 22, 1123, 2013.
16. Berman, D.M., O'Neil, J.J., Coffey, L.C., Chaffanjon, P.C., Kenyon, N.M., Ruiz, P., Jr., et al. Long-term survival of nonhuman primate islets implanted in an omental pouch on a biodegradable scaffold. Am J Transplant 9, 91, 2009.
17. Kenyon, N., Pedraza, E., Berman, D.M., Willman, M., Kenyon, N., Margolles-Clark, E., et al. Scaffolds within an omental pouch site support long term survival of allogeneic, nonhuman primate islets. Amer J Transplant 11, 117. 2011.
18. Pedraza, E., Coronel, M., Fraker, C., Ricordi, C., and Stabler, C. Enhancing beta-cell viability via hydrolytically activated, oxygen generating biomaterials. Proc Natl Acad Sci USA 109, 4245, 2012.
19. Song, Y., Margolles-Clark, E., Fraker, C., Weaver, J.D., Ricordi, C., Pileggi, A., et al. Feasibility of localized immunosuppression: 3. preliminary evaluation of organosilicone constructs designed for sustained drug release in a cell transplant environment using dexamethasone. Pharmazie 67, 502, 2012.
20. Dionne, K.E., Colton, C.K., and Yarmush, M.L. Effect of oxygen on isolated pancreatic tissue. ASAIO Trans 35, 739, 1989.
21. Dionne, K.E., Colton, C.K., and Yarmush, M.L. Effect of hypoxia on insulin secretion by isolated rat and canine islets of Langerhans. Diabetes 42, 12, 1993.
22. Andersson, A., Korsgren, O., and Jansson, L. Intraportally transplanted pancreatic islets revascularized from hepatic arterial system. Diabetes 38 Suppl 1, 192, 1989.
23. Ballian, N., and Brunicardi, F.C. Islet vasculature as a regulator of endocrine pancreas function. World J Surg 31, 705, 2007.
24. Miao, G., Ostrowski, R.P., Mace, J., Hough, J., Hopper, A., Peverini, R., et al. Dynamic production of hypoxia-inducible factor-1alpha in early transplanted islets. Am J Transplant 6, 2636, 2006.
25. Moritz, W., Meier, F., Stroka, D.M., Giuliani, M., Kugelmeier, P., Nett, P.C., et al. Apoptosis in hypoxic human pancreatic islets correlates with HIF-1alpha expression. Faseb J 16, 745, 2002.
26. Linn, T., Schmitz, J., Hauck-Schmalenberger, I., Lai, Y., and Bretzel, R.G., Brandhorst, H., et al. Ischaemia is linked to inflammation and induction of angiogenesis in pancreatic islets. Clin Exp Immunol 144, 179, 2006.
27. Cheng, K., Ho, K., Stokes, R., Scott, C., Lau, S.M., Hawthorne, W.J., et al. Hypoxia-inducible factor-1alpha regulates beta cell function in mouse and human islets. J Clin Invest 120, 2171, 2010.
28. Cantley, J., Grey, S.T., Maxwell, P.H., and Withers, D.J. The hypoxia response pathway and beta-cell function. Diabetes Obes Metab12 Suppl 2, 159, 2010.
29. Cabric, S., Sanchez, J., Johansson, U., Larsson, R., Nilsson, B., Korsgren, O., et al. Anchoring of vascular endothelial growth factor to surface-immobilized heparin on pancreatic islets: implications for stimulating islet angiogenesis. Tissue Eng Part A 16, 961, 2010.
30. Park, K.S., Kim, Y.S., Kim, J.H., Choi, B., Kim, S.H., Tan, A.H., et al. Trophic molecules derived from human mesenchymal stem cells enhance survival, function, and angiogenesis of isolated islets after transplantation. Transplantation 89, 509, 2010.
31. Johansson, U., Rasmusson, I., Niclou, S.P., Forslund, N., Gustavsson, L., Nilsson, B., et al. Formation of composite endothelial cell-mesenchymal stem cell islets: a novel approach to promote islet revascularization. Diabetes 57, 2393, 2008.
32. Shimoda, M., Chen, S., Noguchi, H., Matsumoto, S., and Grayburn, P.A. In vivo non-viral gene delivery of human vascular endothelial growth factor improves revascularisation and restoration of euglycaemia after human islet transplantation into mouse liver. Diabetologia 53, 1669, 2010.
33. Lai, Y., Schneider, D., Kidszun, A., Hauck-Schmalenberger, I., Breier, G., Brandhorst, D., et al. Vascular endothelial growth factor increases functional beta-cell mass by improvement of angiogenesis of isolated human and murine pancreatic islets. Transplantation 79, 1530, 2005.
34. Langlois, A., Bietiger, W., Seyfritz, E., Maillard, E., Vivot, K., Peronet, C., et al. Improvement of rat islet viability during transplantation: validation of pharmacological approach to induce VEGF overexpression. Cell Transplant 20, 1333, 2011.
35. Smith, J.D., Melhem, M.E., Magge, K.T., Waggoner, A.S., and Campbell, P.G. Improved growth factor directed vascularization into fibrin constructs through inclusion of additional extracellular molecules. Microvasc Res 73, 84, 2007.
36. Ucuzian, A.A., Brewster, L.P., East, A.T., Pang, Y., Gassman, A.A., and Greisler, H.P. Characterization of the chemotactic and mitogenic response of SMCs to PDGF-BB and FGF-2 in fibrin hydrogels. J Biomed Mater Res, A. 94, 988, 2010.
37. Sakiyama-Elbert, S.E., Das, R., Gelberman, R.H., Harwood, F., Amiel, D., and Thomopoulos, S. Controlled-release kinetics and biologic activity of platelet-derived growth factor-BB for use in flexor tendon repair. J Hand Surg Am 33, 1548, 2008.
38. Thomopoulos, S., Zaegel, M., Das, R., Harwood, F.L., Silva, M.J., Amiel, D., et al. PDGF-BB released in tendon repair using a novel delivery system promotes cell proliferation and collagen remodeling. J Orthop Res 25, 1358, 2007.
39. Pileggi, A., Molano, R.D., Berney, T., Cattan, P., Vizzardelli, C., Oliver, R., et al. Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 50, 1983, 2001.
40. Martino, M.M., and Hubbell, J.A. The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain. Faseb J 24, 4711, 2010.
41. Martino, M.M., Tortelli, F., Mochizuki, M., Traub, S., Ben-David, D., Kuhn, G.A., et al. Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing. Sci Transl Med 3, 100ra89. 2011.
42. Li, Y., Song, Y., Zhao, L., Gaidosh, G., Laties, A.M., and Wen, R. Direct labeling and visualization of blood vessels with lipophilic carbocyanine dye DiI. Nat Protocols 3, 1703, 2008.
43. Hubbell, J.A. Materials as morphogenetic guides in tissue engineering. Curr Opin Biotechnol 14, 551, 2003.
44. Hubbell, J.A. Materials science. Enhancing drug function. Science 300, 595, 2003.
45. Lutolf, M.P., and Hubbell, J.A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 23, 47, 2005.
46. Zisch, A.H., Zeisberger, S.M., Ehrbar, M., Djonov, V., Weber, C.C., Ziemiecki, A., et al. Engineered fibrin matrices for functional display of cell membrane-bound growth factorlike activities: study of angiogenic signaling by ephrin-B2. Biomaterials 25, 3245, 2004.